نتایج جستجو برای: oral dosing

تعداد نتایج: 277969  

Journal: :The Journal of pharmacology and experimental therapeutics 2014
Martin E Dowty Michael I Jesson Sarbani Ghosh Jamie Lee Debra M Meyer Sriram Krishnaswami Nandini Kishore

A critical piece in the translation of preclinical studies to clinical trials is the determination of dosing regimens that allow maximum therapeutic benefit with minimum toxicity. The preclinical pharmacokinetic (PK)/pharmacodynamic (PD) profile of tofacitinib, an oral Janus kinase (JAK) inhibitor, in a mouse collagen-induced arthritis (mCIA) model was compared with clinical PK/PD data from pat...

2014
Mehul Dave Mike Nash Graeme C. Young Harma Ellens Mindy H. Magee Andrew D. Roberts Maxine A. Taylor Robert W. Greenhill Gary W. Boyle

The absorption, metabolism, and excretion of darapladib, a novel inhibitor of lipoprotein-associated phospholipase A2, was investigated in healthy male subjects using [C]-radiolabeled material in a bespoke study design. Disposition of darapladib was compared following single i.v. and both single and repeated oral administrations. The anticipated presence of low circulating concentrations of dru...

Journal: :Drug metabolism and disposition: the biological fate of chemicals 2014
Mehul Dave Mike Nash Graeme C Young Harma Ellens Mindy H Magee Andrew D Roberts Maxine A Taylor Robert W Greenhill Gary W Boyle

The absorption, metabolism, and excretion of darapladib, a novel inhibitor of lipoprotein-associated phospholipase A2, was investigated in healthy male subjects using [(14)C]-radiolabeled material in a bespoke study design. Disposition of darapladib was compared following single i.v. and both single and repeated oral administrations. The anticipated presence of low circulating concentrations of...

2017
Alexander G.G. Turpie Daniel Purdham Antonio Ciaccia

The nonvitamin K antagonist oral anticoagulants (NOACs), also referred to as direct oral anticoagulants (DOACs), dabigatran, apixaban, edoxaban, and rivaroxaban, have emerged as effective alternatives to vitamin K antagonists (VKAs) across several indications, including the prevention of stroke and systemic embolism (SSE) in patients with atrial fibrillation (AF) and the treatment of venous thr...

2000
Stephen R. Wedge Donald J. Ogilvie Michael Dukes Jane Kendrew Jon O. Curwen Laurent F. Hennequin Andrew P. Thomas Elaine S. E. Stokes Brenda Curry Graham H. P. Richmond Peter F. Wadsworth

There is evidence that vascular endothelial growth factor (VEGF) contributes to solid tumor growth through the promotion of both angiogenesis and tumor vascular permeability. To abrogate VEGF signaling, we developed a small molecular weight inhibitor of VEGF receptor tyrosine kinase (RTK) activity that was compatible with chronic oral administration. ZD4190, a substituted 4-anilinoquinazoline, ...

Journal: :Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics 1985

Journal: :Drug metabolism and disposition: the biological fate of chemicals 1999
C Weber R Gasser G Hopfgartner

The absorption, excretion, and metabolism of the endothelin receptor antagonist bosentan was investigated in healthy male subjects by administration of 14C-labeled compound. Four subjects received a single oral dose of 500 mg of bosentan (3.7 MBq), and four other subjects received a single i.v. dose of 250 mg of bosentan (3.7 MBq). Radioactivity and concentrations of bosentan and its metabolite...

2015
Suman Kanungo Sachin N. Desai Ranjan Kumar Nandy Mihir Kumar Bhattacharya Deok Ryun Kim Anuradha Sinha Tanmay Mahapatra Jae Seung Yang Anna Lena Lopez Byomkesh Manna Barnali Bannerjee Mohammad Ali Mandeep Singh Dhingra Ananga Mohan Chandra John D. Clemens Dipika Sur Thomas F. Wierzba

BACKGROUND A bivalent killed whole cell oral cholera vaccine has been found to be safe and efficacious for five years in the cholera endemic setting of Kolkata, India, when given in a two dose schedule, two weeks apart. A randomized controlled trial revealed that the immune response was not significantly increased following the second dose compared to that after the first dose. We aimed to eval...

Journal: :The Journal of pharmacology and experimental therapeutics 2009
Soratree Charoenthongtrakul Derek Giuliana Kenneth A Longo Elizabeth K Govek Anna Nolan Samantha Gagne Kristen Morgan Jeffrey Hixon Neil Flynn Brian J Murphy Andres S Hernández Jun Li Joseph A Tino David A Gordon Peter S DiStefano Brad J Geddes

The orexigenic peptide ghrelin has been shown to have prokinetic activity in the gastrointestinal (GI) system of several species, including humans. In this series of experiments, we have evaluated the prokinetic activity of novel, small-molecule ghrelin receptor (GhrR) agonists after parenteral and peroral dosing in mice and rats. Gastric emptying, small intestinal transport, and fecal output w...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید